Stay updated on Ipilimumab/Nivolumab in High-Risk Ocular Melanoma Clinical Trial

Sign up to get notified when there's something new on the Ipilimumab/Nivolumab in High-Risk Ocular Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ipilimumab/Nivolumab in High-Risk Ocular Melanoma Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The page revision changed from v3.5.4 to v3.5.5, indicating a new version of the page. This is a metadata update rather than a substantive change to the study information.
    Difference
    0.1%
    Check dated 2026-06-05T08:25:50.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    The page revision updated from v3.5.3 to v3.5.4, signaling a new build deployment. This update does not modify the study content or essential information on the page.
    Difference
    0.1%
    Check dated 2026-05-15T04:59:11.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Version label updated from v3.5.2 to v3.5.3, signaling a new release of the page interface. The update does not modify the study content or data.
    Difference
    0.1%
    Check dated 2026-04-30T18:09:52.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-16T11:05:42.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    Revision added: v3.5.0; revision v3.4.3 removed.
    Difference
    0.1%
    Check dated 2026-03-18T19:52:14.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. This appears to be an internal version update with no changes to study content or eligibility.
    Difference
    0.1%
    Check dated 2026-03-11T17:57:20.000Z thumbnail image

Stay in the know with updates to Ipilimumab/Nivolumab in High-Risk Ocular Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ipilimumab/Nivolumab in High-Risk Ocular Melanoma Clinical Trial page.